Views & Analysis Rethinking access barriers to innovation Market access issues don’t stop once a product has passed HTA – and this is especially true for disruptive therapies like ATMPs.
News Speech analysis tech for ALS gets FDA breakthrough tag Software that can be used to monitor patients with neurodegenerative disorder amyotrophic lateral sclerosis (ALS) using their voice patterns has been granted breakthrough
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?
